COMPANY

Amplifi Vascular

HQ: Chesterfield, MO source · amplifivascular.com ↗

Location: Chesterfield, MO · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: End Stage Kidney Disease (ESRD) End-Stage Renal Disease Requiring Haemodialysis The Amplifi System is a temporary extracorporeal blood pump designed to deliver controlled flow through a peripheral vein for 24-72 hours prior to AVF creation. Amplifi Vein Dilation System

2Trials (company is sponsor)

Timeline

May 12, 2026 Trial start Not phased (device or behavioral study): Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) source ↗
Dec 8, 2020 Trial start Not phased (device or behavioral study): Effect of Amplifi Vein Dilation System Treatment on Radiocephalic AVF Maturation-3 source ↗

Upcoming milestones

Jun 1, 2027 (ESTIMATED) · Not phased · Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) · NCT07211035

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT07211035	Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)	Not phased (device or behavioral study)	Recruiting	May 12, 2026	Jun 1, 2027 (estimated)
NCT07058610	Effect of Amplifi Vein Dilation System Treatment on Radiocephalic AVF Maturation-3	Not phased (device or behavioral study)	Completed	Dec 8, 2020	Jun 11, 2025 (actual)